Skip to content
Riskpilot
← Back to search
Sign in
Get full access
NUPEP AS
AS
Active
Org 928614492
Forskningsparken Gaustadalléen 21, 0349
Oslo
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 2022 · 4 years old
0 employees
Monitor
Share
Norway
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
NUPEP AS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
NOK millions
0M
1M
1M
2M
2M
0M
2022
0M
2023
2M
2024
0M
2025
EBITDA
NOK millions
3M
2M
1M
1M
0M
0M
2022
0M
0%
2023
2M
+200%
2024
0M
-100%
2025
Income statement
NOK thousands
Item
2022
2023
2024
2025
Revenue
431
499
1 678
0
Staff expenses
−0
−34
−0
−0
EBITDA
280
255
1 545
−42
Depreciation & amort.
−0
−25
−94
−94
EBIT
280
230
1 451
−136
Net financials
−2
−30
−5
−1
Profit before tax
278
200
1 446
−137
Tax
61
44
0
−0
Net profit
217
155
1 446
−137
Balance sheet
NOK thousands
Item
2022
2023
2024
2025
Total assets
810
1 650
1 862
1 713
Equity
247
402
403
266
Long-term debt
1
0
0
0
Short-term debt
563
1 247
1 459
1 446
Total debt
563
1 248
1 460
1 446
Financial ratios
5-year trend
EBITDA margin
-4195800.0%
This company
15.8%
Market median
-26555796% vs market
2022
2025
Equity ratio
15.5%
This company
38.2%
Market median
-59% vs market
2022
2025
Return on equity
-51.3%
This company
18.4%
Market median
-379% vs market
2022
2025
Net profit margin
-13652100.0%
This company
8.1%
Market median
-168544544% vs market
2022
2025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2022
2025
Debt / equity
5.43×
This company
0.62×
Market median
-776% vs market
2022
2025
Annual reports & filings
Annual report 2025
Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
More on NUPEP AS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
